NEWS RELEASE: FDA Approval of Generic Abortion Drug “Jarring and Contradictory,” Says Bishop Thomas - October 7, 2025
WASHINGTON – “It is jarring and contradictory that, at the same time that the Food and Drug Administration is conducting a much-needed review of the supposed safety of the abortion pill for women, it is nonetheless approving a new generic for this deadly drug,” said Bishop Daniel E. Thomas, chairman of the United States Conference of Catholic Bishops’ (USCCB) Committee on Pro-Life Activities. Read full statement on the USCCB website by clicking button below.